Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IYH vs. JEHSX: which is better?

Bottom line

IYH vs JEHSX: the short answer

IYH (iShares U.S. Healthcare ETF) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 77% by weight.

IYH is cheaper at 0.37% vs 1.04% — a difference of $67 a year per $10,000 invested.

Over five years, IYH returned +7.0% a year vs +4.2% for JEHSX.

Updated Nov 19, 2026

IYH vs JEHSX side by side

IYHJEHSX
TypeETFMutual fund
Fund familyiSharesJohn Hancock
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.37%1.04%
Annual cost per $10k$37$104
10-yr cost on $10k (prospectus)$468$1,282
Max front loadNone—
12b-1 fee0%0.05%
1-yr return+13.1%+19.5%
5-yr return (annualized)+7.0%+4.2%
10-yr return (annualized)+9.4%+8.7%
Best quarter+15.3%+23.6%
Worst quarter−12.7%−16.1%
Net assets (fund)$3.6B$251.3M
Number of holdings103173
Portfolio turnover3%68%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIYHJEHSXDifference
2025+13.1%+19.5%−6.4%
2024+3.1%+1.8%+1.3%
2023+2.1%+4.3%−2.2%
2022−4.4%−13.1%+8.7%
2021+23.4%+11.2%+12.2%
2020+15.5%+27.2%−11.7%
2019+20.8%+28.7%−7.9%
2018+5.9%+0.7%+5.2%
2017+22.3%+27.5%−5.2%
2016−2.8%−10.6%+7.8%

Source: Fund prospectus bar charts

Holdings overlap

15 of IYH's top 25 holdings also appear in JEHSX's top 25.

Shared top holdings
HoldingIYHJEHSX
Eli Lilly And Company15.11%14.30%
Johnson & Johnson10.17%6.33%
Abbvie Inc.7.32%5.28%
Unitedhealth Group Incorporated6.16%5.95%
Merck & Co., Inc.5.31%4.21%
Thermo Fisher Scientific Incorporated3.52%2.67%
Amgen Inc.3.42%1.90%
Abbott Laboratories3.02%2.00%
Gilead Sciences, Inc.2.66%2.95%
Bristol-myers Squibb Company2.20%2.22%
Intuitive Surgical, Inc.2.05%1.98%
Danaher Corporation2.03%1.51%
Vertex Pharmaceuticals Incorporated2.00%2.38%
Stryker Corporation1.86%1.87%
Elevance Health, Inc.1.34%1.63%

Source: SEC Form N-PORT

IYH top 10

  1. Eli Lilly And Company — 15.11%
  2. Johnson & Johnson — 10.17%
  3. Abbvie Inc. — 7.32%
  4. Unitedhealth Group Incorporated — 6.16%
  5. Merck & Co., Inc. — 5.31%
  6. Thermo Fisher Scientific Incorporated — 3.52%
  7. Amgen Inc. — 3.42%
  8. Abbott Laboratories — 3.02%
  9. Gilead Sciences, Inc. — 2.66%
  10. Pfizer Inc. — 2.35%

JEHSX top 10

  1. Eli Lilly and Company — 14.30%
  2. Johnson and Johnson — 6.33%
  3. UnitedHealth Group Incorporated — 5.95%
  4. AbbVie Inc. — 5.28%
  5. Merck and Co. Inc. — 4.21%
  6. Gilead Sciences Inc. — 2.95%
  7. Thermo Fisher Scientific Inc. — 2.67%
  8. Vertex Pharmaceuticals Incorporated — 2.38%
  9. Bristol-Myers Squibb Company — 2.22%
  10. Abbott Laboratories — 2.00%

FAQ

What is the difference between IYH and JEHSX?
IYH (iShares U.S. Healthcare ETF) and JEHSX (Health Sciences Trust) share a meaningful slice of their top holdings — about 77% by weight. IYH is cheaper at 0.37% vs 1.04% — a difference of $67 a year per $10,000 invested.
Which is cheaper, IYH or JEHSX?
IYH has the lower expense ratio (0.37%).
Should I own both IYH and JEHSX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.